UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Structure-Assisted Design of Mechanism-Based Irreversible Inhibitors of Human Rhinovirus 3C Protease with Potent Antiviral Activity against Multiple Rhinovirus Serotypes

Proceedings of the National Academy of Sciences - PNAS, 1999-09, Vol.96 (20), p.11000-11007

1999

Volltextzugriff (PDF)

In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease

Antimicrobial Agents and Chemotherapy, 1999-10, Vol.43 (10), p.2444-2450

1999

Volltextzugriff (PDF)

Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor

Antimicrobial Agents and Chemotherapy, 2000-05, Vol.44 (5), p.1236-1241

2000

Volltextzugriff (PDF)

Cardiotoxicity Associated with Nicotinamide Phosphoribosyltransferase Inhibitors in Rodents and in Rat and Human-Derived Cells Lines

Cardiovascular toxicology, 2017-07, Vol.17 (3), p.307-318

2017

Volltextzugriff (PDF)

Crystallographic Identification of a Noncompetitive Inhibitor Binding Site on the Hepatitis C Virus NS5B RNA Polymerase Enzyme

Journal of Virology, 2003-07, Vol.77 (13), p.7575-7581

2003

Volltextzugriff (PDF)

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 3. Structure−Activity Studies of Ketomethylene-Containing Peptidomimetics

Journal of medicinal chemistry, 1999-04, Vol.42 (7), p.1203-1212

1999

Volltextzugriff (PDF)

The Crystal Structure of the RNA-Dependent RNA Polymerase from Human Rhinovirus: A Dual Function Target for Common Cold Antiviral Therapy

Structure (London), 2004-08, Vol.12 (8), p.1533-1544

2004

Volltextzugriff (PDF)

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure−Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics

Journal of medicinal chemistry, 2002-04, Vol.45 (8), p.1607-1623

2002

Volltextzugriff (PDF)

Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids

Bioorganic & medicinal chemistry letters, 1999-08, Vol.9 (15), p.2189-2194

1999

Volltextzugriff (PDF)

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 1. Michael Acceptor Structure−Activity Studies

Journal of medicinal chemistry, 1998-07, Vol.41 (15), p.2806-2818

1998

Volltextzugriff (PDF)

Studies on the thermal generation and reactivity of a class of (.sigma.,.pi.)-1,4-biradicals

Journal of the American Chemical Society, 1992-11, Vol.114 (24), p.9369-9386

1992

Volltextzugriff (PDF)

Chemical Structure and Concentration of Intratumor Catabolites Determine Efficacy of Antibody Drug Conjugates

Drug metabolism and disposition, 2016-09, Vol.44 (9), p.1517-1523

2016

Volltextzugriff (PDF)

Recent advances in the development of human rhinovirus 3C protease inhibitors

Expert opinion on therapeutic patents, 2001-02, Vol.11 (2), p.177-184

Dragovich, Peter S

2001

Volltextzugriff (PDF)

Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amides

Bioorganic & medicinal chemistry, 1999-04, Vol.7 (4), p.589-598

1999

Volltextzugriff (PDF)

Design and dynamics of a chemically triggered reaction cascade leading to biradical formation at subambient temperature

Journal of the American Chemical Society, 1989-12, Vol.111 (25), p.9130-9132

1989

Volltextzugriff (PDF)

Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors

Bioorganic & medicinal chemistry letters, 2000-01, Vol.10 (1), p.45-48

2000

Volltextzugriff (PDF)

A reaction cascade leading to 1,6-didehydro[10]annulene → 1,5-dehydronaphthalene cyclization initiated by thiol addition

Journal of the American Chemical Society, 1993-07, Vol.115 (15), p.7021-7022

1993

Volltextzugriff (PDF)

Structure-Based Design of Novel, Urea-Containing FKBP12 Inhibitors

Journal of medicinal chemistry, 1996-04, Vol.39 (9), p.1872-1884

1996

Volltextzugriff (PDF)

An optical thin film assay incorporating rhinovirus protease inhibitors as detector reagents

Antiviral research, 2004-03, Vol.61 (3), p.153-159

2004

Volltextzugriff (PDF)

Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors

Bioorganic & medicinal chemistry letters, 2001-10, Vol.11 (20), p.2683-2686

2001

Volltextzugriff (PDF)

Spectroscopic and crystallographic characterization of (σ2-terpyridyl)Re(CO)3Cl. 2D-NMR evidence for a linkage isomerization reaction

Inorganic chemistry, 1993-01, Vol.32 (2), p.237-241

1993

Volltextzugriff (PDF)

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P1 Lactam Moieties as l-Glutamine Replacements

Journal of medicinal chemistry, 1999-04, Vol.42 (7), p.1213-1224

1999

Volltextzugriff (PDF)

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 2. Peptide Structure−Activity Studies

Journal of medicinal chemistry, 1998-07, Vol.41 (15), p.2819-2834

1998

Volltextzugriff (PDF)

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P 1 Lactam Moieties as l -Glutamine Replacements

Journal of medicinal chemistry, 1999-04, Vol.42 (7), p.1213-1224

1999

Volltextzugriff (PDF)

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. Part 7: Structure–Activity Studies of Bicyclic 2-Pyridone-Containing Peptidomimetics

Bioorganic & medicinal chemistry letters, 2002-03, Vol.12 (5), p.733-738

2002

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(115)

Publikationsform

Sprache

Englisch
(139)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(59)
Humans
(48)
Pharmacology & Pharmacy
(29)
Biological And Medical Sciences
(28)
Medical Sciences
(26)
Physical Sciences
(24)
Chemistry
(23)
Chemistry, Medicinal
(22)
Male
(19)
Pharmacology. Drug Treatments
(19)
Structure-Activity Relationship
(18)
Chemistry, Organic
(17)
3c Viral Proteases
(16)
Animals
(15)
Female
(15)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(14)
Antiviral Agents
(14)
Middle Aged
(14)
Antiviral Agents - Pharmacology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Structure-Assisted Design of Mechanism-Based Irreversible Inhibitors of Human Rhinovirus 3C Protease with Potent Antiviral Activity against Multiple Rhinovirus Serotypes

In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease

Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor

Cardiotoxicity Associated with Nicotinamide Phosphoribosyltransferase Inhibitors in Rodents and in Rat and Human-Derived Cells Lines

Crystallographic Identification of a Noncompetitive Inhibitor Binding Site on the Hepatitis C Virus NS5B RNA Polymerase Enzyme

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 3. Structure−Activity Studies of Ketomethylene-Containing Peptidomimetics

The Crystal Structure of the RNA-Dependent RNA Polymerase from Human Rhinovirus: A Dual Function Target for Common Cold Antiviral Therapy

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure−Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics

Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 1. Michael Acceptor Structure−Activity Studies

Studies on the thermal generation and reactivity of a class of (.sigma.,.pi.)-1,4-biradicals

Chemical Structure and Concentration of Intratumor Catabolites Determine Efficacy of Antibody Drug Conjugates

Recent advances in the development of human rhinovirus 3C protease inhibitors

Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amides

Design and dynamics of a chemically triggered reaction cascade leading to biradical formation at subambient temperature

Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors

A reaction cascade leading to 1,6-didehydro[10]annulene → 1,5-dehydronaphthalene cyclization initiated by thiol addition

Structure-Based Design of Novel, Urea-Containing FKBP12 Inhibitors

An optical thin film assay incorporating rhinovirus protease inhibitors as detector reagents

Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors

Spectroscopic and crystallographic characterization of (σ2-terpyridyl)Re(CO)3Cl. 2D-NMR evidence for a linkage isomerization reaction

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P1 Lactam Moieties as l-Glutamine Replacements

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 2. Peptide Structure−Activity Studies

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P 1 Lactam Moieties as l -Glutamine Replacements

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. Part 7: Structure–Activity Studies of Bicyclic 2-Pyridone-Containing Peptidomimetics

Suchergebnisse filtern